Zobrazeno 1 - 10
of 24
pro vyhledávání: '"M L Givner"'
Autor:
M L Givner, L Lehmann, R Douglas, E C Abbott, M H Tan, S R Salisbury, S E York, A H Shlossberg, S Reddy, R S Rittmaster
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 83:814-818
Medical treatment of Graves' disease involves antithyroid drugs with or without the addition of exogenous T4. There have been conflicting reports as to whether the addition of T4 improves remission rates or delays relapse. To evaluate this issue in a
Publikováno v:
The Journal of clinical endocrinology and metabolism. 83(3)
Testolactone, an aromatase inhibitor, blocks conversion of androgens to estrogens. In familial male precocious puberty, slowing of pubertal progression and growth velocity occurs with testolactone and spironolactone. Girls with McCune-Albright syndro
Autor:
I S, Sketris, J G, Lawen, L, Beauregard-Zollinger, P, Belitsky, D, Landsberg, M L, Givner, P, Keown
Publikováno v:
Transplantation proceedings. 26(5)
Autor:
M. L. Givner, M. A. Hirsch
Publikováno v:
Canadian Journal of Physiology and Pharmacology. 54:405-408
An in vivo method for the determination of biological potency of luteinizing hormone -releasing hormone (LH–RH) antiserum is described. The procedure involves antiserum blockade of LH–RH induced ovulation in immature rats primed with pregnant mar
Autor:
M. L. Givner, C. Auclair
Publikováno v:
Archives of Andrology. 8:21-24
Treatment (5 mg/kg s.c. for 1 to 4 weeks) of adult male rats with medrogestone (Colprone), a compound with progestational and antiandrogenic properties, induced significant atrophy of the ventral prostate without affecting testicular weight, testicul
Autor:
M. L. Givner, U. K. Banik
Publikováno v:
Reproduction. 44:87-94
Pro-oestrous rats, treated with fluphenazine dihydrochloride to block ovulation, were used to compare the ovulation-inducing activity of synthetic LH-RH with one of its analogues, [D-Ala-6, des-Gly-NH2-10]-LH-RH ethylamide (AY-25,205). The lowest dos
Autor:
N. Jagarinec, M. L. Givner
Publikováno v:
Archives of Andrology. 7:39-44
Medrogestone (MDG), viz., 6,17-dimethyl-4,6-pregnadiene-3,20-dione (Colprone), a synthetic compound with progestational and antiandrogenic properties was studied for its effect on the conversion of testosterone (T) to 5 alpha-dihydrotestosterone (DHT
Publikováno v:
Endocrinology. 83:555-564
Oral administration of the cholesterol biosynthesis inhibitor AY-9944 [trans-1,4- bis(2-chlorobenzylaminomethyl)cyclohexane dihydrochloride] did not affect the steroidogenic response to injected ACTH in hypophysectomized rats nor to laparotomy stress
Publikováno v:
Endocrinology. 81:976-980
AY-9944 [trans-1,4-bis(2-chlorobenzylaminomethyl) cyclohexane dihydroohloride], an inhibitor of cholesterol biosynthesis, was studied for its effect on adrenal corticoid synthesis. In rat adrenal homogenates AY-9944 inhibited the production of cortic
Autor:
J. G. Rochefort, M. L. Givner
Publikováno v:
Endocrinology. 90:1238-1244
Medroxyprogesterone acetate, chlormadinone acetate, AY-11,497 and clogestone acetate (AY-11,440) reduced adrenal and ovarian weights, serum and adrenal corticosterone in the rat. Adrenal homogenates from rats treated with medroxyprogesterone acetate